7th International Symposium on  Ocular

Pharmacology and Therapeutics


 February 28 - March 2, 2008
Budapest, Hungary




Invited Lecures

A European Network of Certified Clinical Trials Centres of Ophthalmology – EVI.CT.SE
J. Cunha-Vaz

Management Strategies for Diabetic Macular Edema
J. Cunha-Vaz, J. Figueira, C. Lobo and I. Pires

Results of a Phase I Study of Intravitreal VEGF Trap in Subjects with Diabetic Macular Edema: The Clear-It DME Study
D.V. Do, Q.D. Nguyen, D.J. Browning, S.M. Shah, K. Chu, J. Buskey, I. Grimes, A. Ingerman, J.M. Cedarbaum and P. Campochiaro

Anti-Angiogenic Therapy in Retinopathy of Prematurity
K.A. Drenser, M.T. Trese, A. Capone, Jr. and W. Dailey

Medicated Intraocular Lenses
S. Eperon, L. Bossy-Nobs, I.K. Petropoulos, R. Gurny and Y. Guex-Crosier

Treatment of Diabetic Macular Edema with Pegaptanib Sodium (Macugen®)
E. Ergun

Combination Brachytherapy and Anti-VEGF Therapy for CNV in AMD
J. Heier

JSM6427, a Small Molecule a5b1Integrin Inhibitor
J.S. Heier, A.J. Berman, G. Zahn, D.T. Shima and A.P. Adamis

Functional Imaging of the Eye
L. Kagemann and A. Harris

Increasing Outflow Facility – Today and Tomorrow
P. Kaufman

In vitro and In vivo Susceptibility – An Anti-Infective Interaction Review
R.P. Kowalski, E.G. Romanowski, F.S. Mah, R.M.Q. Shanks and Y.J. Gordon

Anti-Oxidants and Diabetic Retinopathy
R.A. Kowluru and M. Kanwar

Nitric Oxide (NO) in the Regulation of Intraocular Pressure
J. Maenpaa, H. Kotikoski, E. Aine, P. Alajuuma, O. Oksala and H. Vapaatalo

Inhibitory Effect of Green Tea Extracts on Lipid Peroxidation Induced by Rose Bengal and Blue Light Exposure in Porcine Retinal Homogenate
T. Nakanishi-Ueda, T. Ueda, M. Aburada, T. Shimada, R. Koide and H. Yasuhara

Cyclosporin A and Tacrolimus
A.A. Okada

Is Cyclooxygenase a Rational Therapeutic Target for Retinal Angiogenesis?
S. Yanni and J. Penn



Free papers

Novel Formulation of an Ocular Hypotensive Melatonin MT3 Receptor Agonist (5-MCANAT)
V. Andrés-Guerrero, P. Alarma-Estrany, A. Peral, M. Vicario, D. Barbosa, J. Pintor and R. Herrero-Vanrell

Safety and Efficacy Clinic Trial of 0.03% Meloxicam Ophthalmic Solution Versus Diclofenac in the Postsurgical of Lasik Refractive Surgery
L.M. Baiza-Duran, J. Quintana-Hau, R. Tornero-Montaño, L. Alanis-Villarreal, G. Avalos-Urzua, J.L. Domene-Hinojosa, P. Gómez-Bastar, M.A. Ibañez-Hernandez, A. Mendez-Noble, J. Navarro-Sanchez, G. Velasco-Gallegos, R. Velasco-Ramos and D. Viggiano-Austria

In Vitro Toxicity of Preservative-Free Tafluprost and Preserved Latanoprost, Travoprost and Bimatoprost: A Study on Conjunctival Epithelial Cells
E. Brasnu, H. Liang, F. Brignole-Baudouin, L. Riancho, J.-M. Guenoun, J.-M. Warnet and C. Baudouin

GDNF-Loaded PLGA Microparticles for Intravitreous Administration. Effect of BSA% on the In Vitro Release Rate
P. Checa-Casalengua, I. Bravo-Osuna, S. Sacristán, I.T. Molina-Martínez, M.J. Young and R. Herrero-Vanrell

Chitosan-Based Colloidal Systems as Promising Topical Drug Carriers for Ocular Surface Disorders
Y. Diebold, L. Contreras-Ruiz, A. López-García, M. Calonge, M. de la Fuente, B. Seijo, A. Sánchez and M.J. Alonso

Circulatory Parameters in the Retrobulbar Central Retinal Artery and Vein of Patients with Diabetes and Medically Treated Systemic Hypertension
G. Dimitrova, S. Kato, H. Fukushima and H. Yamashita

N-Acetyl-L-Cysteine Reduces Lens Damage from High Glucose
Y. Dovrat, E. Bormusov and A. Dovrat

Hypotensive Preparation of Patients Before Antiglaucoma Operation
V.V. Egorov, A.V. Postupaev, A.V. Vasiliev and A.V. Egorova

Monotherapy by Diclo-f Drops in Postoperative Treatment of Patients After Antiglaucoma Operation
V.V. Egorov, A.V. Postupaev, A.V. Vasiliev and A.V. Egorova

Comparison of the Diurnal Intraocular Pressure-Lowering Efficacy of Bimatoprost 0.03%, Latanoprost 0.005% and Travoprost 0.004% in Patients with Glaucoma
A. Ferreras, A.B. Pajarín, L.E. Pablo, J.M. Larrosa and V. Polo

Effect on Intraocular Pressure Achieved with Bimatoprost in Glaucoma Patients Previously Treated with the Fixed-Combination of Latanoprost and Timolol
A. Ferreras, A.B. Pajarín, V. Polo and J.M. Larrosa

Effect of a-Lipoic Acid on Electroretinographic Changes in Early Experimental Diabetic Retinopathy
M. Garcia-Pous, S. Garcia-Delpech, M. Diaz-Llopis, F. Bosch-Morell, S. Soriano, J. Romero, P. Udaondo and D. Salom

In Vitro Susceptibility to Different Topical Ophthalmic Antibiotics of Bacterial Isolates in Patients with Conjunctivitis
F. Giardini, M. Vana, U. de Sanctis, C. Eandi, F. Machetta, C. Pollino and F.M. Grignolo

Efficacy and Safety of Latanoprost Versus the Pilocarpine/Timolol Maleate Fixed Combination in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
J. Ka³uzny, R. Sobecki, K. Czechowicz-Janicka, D. Kecik, J.A. Stewart and W.C. Stewart

Effects of Intravitreal Bevacizumab on Neovascular Glaucoma
E. Kirii, T. Yamamoto, M. Nagasawa, N. Mochizuki, S. Nakano and H. Yamashita

Comparison of VEGF Antagonists in an In Vitro System
A. Klettner and J. Roider

The Encyclopedia of Topical Glaucoma Medication: Evidence from Randomised Controlled Trials
C.-W. Lee, F. Buckley, S. Costello and S. Kelly

Choroidal Neovascularization Uveitis Associated
F. Mandelblum, J. Mandelblum, N. Ramirez and JL. Murcia

Neovascular Glaucoma Sequential Therapy by Anti-Angiogenic Treatment with IVT Bevacizumab and Glaucoma Drainage Implant (Ex-press): A Pilot Study
T. Micelli Ferrari, M. Leozappa and E. Epifani

Slow Intraocular Release System Production of Triamcinolone Acetonide
H.M. Nascimento, J. Mitre, M. Cunial, R. Montesinos and J. Mitre

Comparison of Twice Daily and Three Times Daily Dosing of Dorzolamide in Ocular Hypertensive and Glaucoma Patients Treated with Latanoprost
P.A. Netland, A.P.C. Lupinacci, K.H. Fung, D. Evans and Y. Zhao

Misregulation of Rhodopsin Phosphorylation and Dephosphorylation is a Common Mechanism in P23H and S334ter Retinal Degeneration
H. Ohguro, H. Kawata, S. Tanaka and I. Ohguro

Effects of Anthocyanins in Black Currant on Retinal Blood Flow Circulation of Patients with Normal Tension Glaucoma
I. Ohguro, S. Tanaka, H. Kawata and H. Ohguro

Intravitreal Pegaptanib Sodium for Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
P. Udaondo, S. Garcia-Delpech, D. Salom, F. Bosch amd M. Diaz-Llopis

Intravitreal Pegaptanib Sodium Injection as a Treatment for Refractory Pseudophakic Cystoid Macular Edema
P. Udaondo, S. Garcia-Delpech, D. Salom, E. Cervera and M. Diaz-Llopis

Intravitreal Toxicity of Linezolid
P. Udaondo, S. Garcia-Delpech, D. Salom, M. Garcia-Pous and M. Díaz-Llopis

Adalimumab Therapy for Refractory Uveitis: A Pilot Study
P. Udaondo, S. Garcia-Delpech, D. Salom, M. Hernandez-Garfella and M. Díaz-Llopis

Bacterial Endophthalmitis Treated with Linezolid
P. Udaondo, S. Garcia-Delpech, D. Salom, B. Moratal-Peiro and M. Díaz-Llopis

Effectiveness of Brilliant Blue G for Capsular Staining for Continuous Curvilinear Capsulorhexis
P. Udaondo, S. Garcia-Delpech, D. Salom, FJ. Romero and M. Díaz-Llopis

Mechanism of Action of Latanoprost – New Aspects
W.D. Ulrich, A. Moeller, Ch. Ulrich, K.D. Wernecke and G. Siebert

Increase of Serum Alanine / Asparate Tranferase Associated with Prostaglandin Anti-glaucoma Drugs
X. Wu, L. Wu and W. Wang

Ocular Complications of Amiodarone Therapy
I. Zolog, M. Munteanu and E. Popovici

 MEDIMOND s.r.l. - Via Verdi, 15/1 - 40067 Pianoro (BO) Italy